Improving lives and health outcomes.

Ipsen’s vision is to be a leading global mid-size biopharmaceutical company, with a focus on transformative medicines in three key therapeutic areas: oncology, rare disease and neuroscience.

About Ipsen

At Ipsen, we’re dedicated to improving people’s lives and health outcomes. Our 5,700 employees around the world are committed to tackling areas of high unmet medical need to improve the quality of life of patients and caregivers.

Our Strategy

Under the overarching theme of Focus. Together. For patients & society, Ipsen is focusing on four strategic priorities to accelerate our innovation and drive positive impact for patients, employees, shareholders and society—a strategy for the short and long term.

Executive management

* members of the Executive Leadership Team

David Loew*

Chief Executive Officer

Bartosz (Bartek) Bednarz*

Executive Vice President,

Head of Global Product and Portfolio Strategy

Dominique Bery*

Executive Vice President,

Strategy & Transformation

Stewart Campbell*

Executive Vice President,

President of North America

François Garnier*

Executive Vice President,

General Counsel

Benoît Hennion*

Executive Vice President,

Consumer Healthcare

Steven Hildemann*, M.D., Ph.D.

Executive Vice President,

Chief Medical Officer, Head of Global Medical Affairs, Patients Safety and Patients Affairs

Dominique Laymand*

Executive Vice President,

Ethics and Social Responsibility Officer

Aymeric Le Chatelier*

Executive Vice President,

Group Chief Financial Officer

Philippe Lopes-Fernandes*

Executive Vice President,

Chief Business Officer

Howard Mayer*, M.D

Executive Vice President,

Head of Research and Development.

Régis Mulot*

Executive Vice President,

Chief Human Resources Officer

Aidan Murphy*, Ph.D.

Executive Vice President,

Technical Operations

Mari Scheiffele*

Executive Vice President,

Specialty Care International

Gwenan White*

Executive Vice President,

Communications and Public Affairs

Board Committees

The Board of Directors has set up six permanent committees and has defined both the composition and powers of these committees.

Our History

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2021